arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Harrow, Inc.

HROW Health Care Biotechnology: Pharmaceutical Preparations
$28.44
▲ +0.7% Today
as of Oct 23, 16:49 ET
Last 30 days -16.52% Sep 14 → Oct 23
$26.66 $28.75 $30.85 $32.94 $35.03 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$27.76
High
$28.54
Low
$27.14
Volume
$854,568
Avg Vol
$679,894
Mkt Cap
$1.1B
P/E (TTM)
—
Beta
—
52w High
$54.85
52w Low
$26.96
Div Yield
—
Shares Out
$37M

Recent Press Releases & News last 60 days · 8 items

Oct 18 · 15:12 Simply Wall St.
Is Harrow (HROW) Below Fair Value Based On Its Sales?
Oct 9 · 11:46 Zacks
Do Options Traders Know Something About Harrow Stock We Don't?
Oct 8 · 01:15 Simply Wall St.
Is Harrow (HROW) Undervalued On Growing Conference Buzz Around Its Ophthalmic Pipeline?
▸ Show all 8 press releases & news Free account →

HROW earnings at a glance

The options market is pricing a move of about ±13.1% after the report, a range of roughly $24.71 to $32.17 from today's $28.44. Over its last 2 reports the stock rose the next day 0 times and fell 2, moving ±2.3% on average; after the most recent report on May 11, 2026 it moved -0.5%. That means options currently expect more movement than HROW has typically delivered. HROW beat the consensus EPS estimate in 1 of its last 3 reported quarters. Implied volatility is currently 111%. The share price of $28.44 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$27
$55
5% of range
Avg surprise (last 3)
-665.5%
Avg reaction (last 2)
-2.3%
0% positive
Latest IV / EM
111%
EM ±13.1% · $31 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.63$-0.39$-0.15$0.09$0.33 Actual $-0.22Actual $-0.14Actual $-0.13Actual $-0.38Actual $-0.18Actual $-0.12Actual $-0.38Est $0.02Actual $0.24Actual $0.33Est $0.22Actual $-0.63Est $-0.43Actual $-0.46 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-28M$-2M$24M$50M$75M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.46 — — — — financials
Mon May 11, 2026Mar/2026 $-0.63 $-0.43 -46.5% -65.8% -0.5% earnings
Mon Nov 10, 2025Sep/2025 $0.33 $0.22 +50.0% — — earnings
Mon Aug 11, 2025Jun/2025 $0.24 — — — — earnings
Thu May 8, 2025Mar/2025 $-0.38 $0.02 -2,000% — -4.1% earnings
Mon Sep 30, 2024Sep 2024 $-0.12 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.18 — — — — financials
Sun Mar 31, 2024Mar 2024 $-0.38 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.13 — — — — financials
Fri Jun 30, 2023Jun 2023 $-0.14 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.22 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$71M$44M—$72M$64M$48M—$49M
Cost of revenue$20M$17M—$18M$16M$16M—$12M
Gross profit$50M$27M—$54M$48M$32M—$37M
Operating income$-11M$-22M—$15M$11M$-11M—$1M
Net income$-17M$-28M—$1M$5M$-18M—$-4M
EPS (diluted)$-0.46$-0.74—$0.03$0.13$-0.50—$-0.12

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$84M$95M$73M$74M$53M$67M$47M$73M
Inventory$17M$16M$14M$13M$12M$11M$11M$10M
Total current assets$229M$226M$212M$178M$155M$170M$190M$147M
Total assets$417M$420M$399M$363M$345M$364M$389M$352M
Long-term debt—$300M—$347M$251M$257M—$231M
Total liabilities$402M$391M$347M$316M$296M$308M$320M$294M
Total equity$15M$28M$52M$47M$49M$56M$70M$58M

Implied volatility — last 90 days

33%65%98%131%164% Jun 07 — IV 95% · EM ±13.1%Jun 08 — IV 65% · EM ±8.6%Jun 09 — IV 100% · EM ±12.6%Jun 10 — IV 70% · EM ±8.2%Jun 11 — IV 73% · EM ±8.1%Jun 12 — IV 92% · EM ±9.4%Jun 15 — IV 84% · EM ±6.1%Jun 16 — IV 130% · EM ±7.7%Jun 17 — IV 164% · EM ±6.9%Jun 19 — IV 54% · EM ±11.8%Jun 22 — IV 57% · EM ±11.9%Jun 23 — IV 60% · EM ±12.2%Jun 24 — IV 65% · EM ±13.1%Jun 25 — IV 62% · EM ±12.1%Jun 26 — IV 66% · EM ±12.6%Jun 29 — IV 68% · EM ±12.1%Jun 30 — IV 59% · EM ±10.2%Jul 01 — IV 46% · EM ±7.7%Jul 02 — IV 62% · EM ±10.0%Jul 03 — IV 64% · EM ±10.0%Jul 06 — IV 49% · EM ±6.8%Jul 07 — IV 63% · EM ±8.3%Jul 08 — IV 80% · EM ±10.0%Jul 09 — IV 72% · EM ±8.6%Jul 13 — IV 100% · EM ±8.4%Jul 15 — IV 116% · EM ±6.9%Jul 16 — IV 72% · EM ±3.0%Jul 20 — IV 81% · EM ±19.2%Jul 21 — IV 85% · EM ±19.7%Jul 22 — IV 85% · EM ±19.5%Jul 23 — IV 81% · EM ±18.2%Jul 24 — IV 82% · EM ±18.0%Jul 27 — IV 82% · EM ±17.2%Jul 28 — IV 85% · EM ±17.5%Jul 29 — IV 91% · EM ±18.2%Jul 30 — IV 98% · EM ±19.2%Jul 31 — IV 96% · EM ±18.3%Aug 03 — IV 108% · EM ±19.1%Aug 04 — IV 92% · EM ±15.8%Aug 05 — IV 110% · EM ±18.5%Aug 06 — IV 96% · EM ±15.5%Aug 07 — IV 89% · EM ±14.0%Aug 10 — IV 114% · EM ±15.8%Aug 11 — IV 79% · EM ±10.4%Aug 13 — IV 72% · EM ±8.5%Aug 14 — IV 86% · EM ±9.5%Aug 17 — IV 108% · EM ±9.0%Aug 18 — IV 135% · EM ±9.7%Aug 19 — IV 43% · EM ±2.5%Aug 20 — IV 151% · EM ±6.3%Aug 24 — IV 53% · EM ±11.1%Aug 25 — IV 52% · EM ±10.6%Aug 26 — IV 54% · EM ±10.7%Aug 27 — IV 58% · EM ±11.4%Aug 28 — IV 55% · EM ±10.5%Aug 31 — IV 45% · EM ±7.9%Sep 01 — IV 62% · EM ±10.8%Sep 02 — IV 52% · EM ±8.6%Sep 03 — IV 62% · EM ±10.0%Sep 04 — IV 68% · EM ±10.6%Sep 07 — IV 76% · EM ±10.6%Sep 08 — IV 82% · EM ±10.9%Sep 09 — IV 87% · EM ±10.9%Sep 10 — IV 33% · EM ±3.9%Sep 11 — IV 70% · EM ±7.8%Sep 14 — IV 135% · EM ±11.3%Sep 15 — IV 65% · EM ±4.7%Sep 16 — IV 101% · EM ±6.0%Sep 21 — IV 47% · EM ±9.8%Sep 22 — IV 47% · EM ±9.6%Sep 23 — IV 50% · EM ±10.0%Sep 24 — IV 54% · EM ±10.6%Sep 25 — IV 55% · EM ±10.5%Sep 28 — IV 49% · EM ±8.6%Sep 29 — IV 72% · EM ±12.3%Sep 30 — IV 67% · EM ±11.2%Oct 01 — IV 75% · EM ±12.1%Oct 02 — IV 65% · EM ±10.2%Oct 06 — IV 42% · EM ±5.6%Oct 08 — IV 111% · EM ±13.1%

Sector peers

MNKD
MannKind Corporation
$1.1B $3.19+4.6%
JANX
Janux Therapeutics, Inc.
$1.1B $16.66-1.6%
DMRA
Damora Therapeutics, Inc.
$1.2B $21.09-2.0%
OPK
Opko Health, Inc.
$1.0B $1.63+1.9%
PCRX
Pacira BioSciences, Inc.
$1.0B $36.42+0.2%
ORIC
Oric Pharmaceuticals, Inc.
$1.3B $13.17-4.9%

HROW earnings FAQ

What is HROW's expected move for earnings?

Options currently price a move of about ±13.1%, or $3.73 per share either way from $28.44.

How does HROW stock usually react to earnings?

Across the last 2 reports the average next-day move was ±2.3%, up 0 times and down 2 times.

What is HROW's implied volatility?

HROW's at-the-money implied volatility is about 111% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in